Novartis AG (NVS)
147.18
+2.18
(+1.50%)
USD |
NYSE |
Jan 23, 16:00
147.18
0.00 (0.00%)
After-Hours: 17:32
Novartis Cash from Investing (Quarterly): -858.23M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Amgen, Inc. | -414.00M |
| AstraZeneca PLC | -2.088B |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Avidity Biosciences, Inc. | -587.93M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.574B |
| Cash from Financing (Quarterly) | -2.754B |
| Free Cash Flow | 17.15B |
| Free Cash Flow Per Share (Quarterly) | 2.961 |
| Free Cash Flow to Equity (Quarterly) | 6.359B |
| Free Cash Flow to Firm (Quarterly) | 6.007B |
| Free Cash Flow Yield | 5.91% |